• Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023

  • Belgium reclaims second place in European biotech ranking

    Wednesday May 31st 2023

  • Biotech in Vlaanderen: een straf verhaal

    Wednesday May 31st 2023

  • Mithra appoints experienced life sciences executive Christian Homsy* as Chairman

    Tuesday May 30th 2023

  • Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Friday May 26th 2023

  • How garbage disposal clogs in cells can lead to Alzheimer’s

    Friday May 26th 2023

  • The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services

    Thursday May 25th 2023

  • GEVERS, the torch is passed

    Thursday May 25th 2023

  • Your news here?

  • The QbD Group acquires Michor Consulting to enhance its regulatory affairs services across Europe

    Thursday May 25th 2023

  • Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis

    Wednesday May 24th 2023

  • Scientists shed light on a sleep peptide involved in Alzheimer’s

    Wednesday May 17th 2023


Strategic Partners